Key transaction details
Director Scott Geoffrey Gates of Aehr Test Systems (NASDAQ:AEHR) sold 35,000 shares of common stock on April 9, 2026, for approximately $2.37 million. The sales were carried out across multiple trades at prices ranging from $67.75 to $68 per share, according to a Form 4 filing with the Securities and Exchange Commission.
Position and ownership after the sale
The Form 4 filing indicates the shares sold were indirectly owned by Mr. Gates through his spouse. After the April 9 transactions, Mr. Gates indirectly holds 105,000 shares via his spouse. In addition to those indirect holdings, Mr. Gates directly owns 52,864 shares, a figure that includes shares subject to unvested restricted stock units, and he indirectly holds 60,686 shares through a trust.
Market context
The timing of the sale comes as Aehr Test Systems shares trade near their 52-week high of $72.50, following an exceptional 727% increase over the past year. Separate analysis from InvestingPro included in the filing's summary characterizes the stock as appearing overvalued at current levels and notes that investors can access 19 additional ProTips and comprehensive Pro Research Reports for further study.
Recent financial results
In other company developments, Aehr Test Systems reported mixed financial results for the third quarter of fiscal 2026. The firm posted an earnings per share of -$0.05, beating the forecasted -$0.07, while revenue missed expectations at $10.3 million versus the anticipated $10.8 million. Offsetting the revenue shortfall, the company disclosed strong quarterly bookings of $37.2 million and a book-to-bill ratio exceeding 3.5 times.
Analyst response
Following those results, Lake Street adjusted its price target on Aehr Test Systems to $56 from $50 and maintained a Buy rating. Lake Street cited the company's strong bookings momentum as a constructive factor in its outlook.
Takeaway
The disclosed April 9 sale and the detailed ownership breakdown provide a clear picture of Mr. Gates' holdings following the transactions. At the same time, the company's latest quarter presents a mix of operational signals - an EPS beat, a revenue shortfall, robust bookings, and an analyst price-target increase - that together outline the recent developments for Aehr Test Systems.
Note: All factual details in this article are drawn from filings and the company disclosure described above.